iBio(IBIO)

NEW YORK, NY

Biotechnology

Website LinkedIn Careers Page

Focus: Antibody Therapies

iBio is a life sciences company focused on Antibody Therapies.

Oncology

Funding Stage

PUBLIC

Employees

1-50

Open Jobs

Pipeline & Clinical Trials

PHI-101 administration

Platinum-resistant Ovarian Cancer

Phase 1

Clinical Trials (1)

NCT04678102Chk2 Inhibitor for Recurrent EpitheliAl periToneal, fallopIan or oVarian cancEr (CREATIVE Phase IA Trial)

Phase 1

PHI-101

Relapsed or Refractory Acute Myeloid Leukemia

Phase 1

Clinical Trials (1)

NCT04842370Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PHI 101 for the Treatment of AML

Phase 1

Open Jobs (2)

Executive Assistant (Onsite)

San Diego, CA

2w ago

Research Associate, In Vivo Pharmacology (Contract)

San Diego, CA

1mo ago

Interview Prep Quick Facts

Portfolio: 2 clinical trials

SEC Filings: 2 available

Open Roles: 2 active jobs

Financials (FY2025)

Revenue

$225K

R&D Spend

$5M(2304%)50%

Net Income

-$25M

Cash

$14M

Source: SEC 10-K Filing

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles